Unachieved antiviral strategies with acyclic nucleoside phosphonates: Dedicated to the memory of dr. Salvatore "Sam" Joseph Enna

被引：6
作者：
De Clercq, Erik [1 ]
Li, Guangdi [2 ]
Zhang, Yun [3 ]
Huang, Jie [2 ]
Tan, Li [4 ]
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
[2] Cent South Univ, Xiangya Sch Publ Hlth, Changsha 410078, Peoples R China
[3] Huaihua City Maternal & Child Hlth Care Hosp, Huaihua 418000, Peoples R China
[4] Cent South Univ, Xiangya Hosp 2, Hunan Clin Mol Diag Ctr, Clin Med Res Ctr Mol Diag Infect Dis Hunan Prov,Mo, Changsha 410011, Peoples R China
来源：
BIOCHEMICAL PHARMACOLOGY | 2024年 / 228卷
关键词：
Acyclic nucleoside phosphonates; Drug discovery; Tenofovir; Cidofovir; RECURRENT RESPIRATORY PAPILLOMATOSIS; POLYOMAVIRUS BK REPLICATION; INTRALESIONAL CIDOFOVIR; LARYNGEAL PAPILLOMATOSIS; IN-VITRO; VIRUS-REPLICATION; NUCLEOTIDE ANALOG; AMIDATE PRODRUGS; DNA-POLYMERASE; DOUBLE-BLIND;
D O I：
10.1016/j.bcp.2024.116448
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Many acyclic nucleoside phosphonates such as cidofovir, adefovir dipivoxil, tenofovir disoproxil fumarate, and tenofovir alafenamide have been marketed for the treatment or prophylaxis of infectious diseases. Here, this review highlights potent acyclic nucleoside phosphonates for their potential in the treatment of retrovirus (e.g., human immunodeficiency virus) and DNA virus (e.g., adeno-, papilloma-, herpes- and poxvirus) infections. If properly assessed and/or optimized, some potent acyclic nucleoside phosphonates can be possibly applied in the control of current and emerging infectious diseases.
引用
收藏
页数：10
相关论文
共 105 条
[51]   Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents [J].
Krecmerova, Marcela ;
Holy, Antonin ;
Andrei, Graciela ;
Pomeisl, Karel ;
Tichy, Tomas ;
Brehova, Peter ;
Masojidkova, Milena ;
Dracinsky, Martin ;
Pohl, Radek ;
Laflamme, Genevieve ;
Naesens, Lieve ;
Hui, Hon ;
Cihlar, Tomas ;
Neyts, Johan ;
De Clercq, Erik ;
Balzarini, Jan ;
Snoeck, Robert .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) :6825-6837
[52]   Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position [J].
Krecmerova, Marcela ;
Masojidkova, Milena ;
Holy, Antonin .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (01) :387-395
[53]   Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults [J].
Kupfer, Robbi A. ;
Tatar, Emel Cadalli ;
Barry, Jonnae O. ;
Allen, Clint T. ;
Merati, Albert L. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 154 (04) :689-692
[54]   Development of CMX001 for the Treatment of Poxvirus Infections [J].
Lanier, Randall ;
Trost, Lawrence ;
Tippin, Tim ;
Lampert, Bernhard ;
Robertson, Alice ;
Foster, Scott ;
Rose, Michelle ;
Painter, Wendy ;
O'Mahony, Rose ;
Almond, Merrick ;
Painter, George .
VIRUSES-BASEL, 2010, 2 (12) :2740-2762
[55]   Memorial Tribute to Salvatore "Sam" Joseph Enna- Editorial [J].
Lash, Larry .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 388 (01) :6-7
[56]   Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis [J].
Lee, AS ;
Rosen, CA .
JOURNAL OF VOICE, 2004, 18 (04) :551-556
[57]   Therapeutic strategies for COVID-19: progress and lessons learned [J].
Li, Guangdi ;
Hilgenfeld, Rolf ;
Whitley, Richard ;
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (06) :449-475
[58]   Approved HIV reverse transcriptase inhibitors in the past decade [J].
Li, Guangdi ;
Wang, Yali ;
De Clercq, Erik .
ACTA PHARMACEUTICA SINICA B, 2022, 12 (04) :1567-1590
[59]   A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021) [J].
Li, Guangdi ;
De Clercq, Erik .
MEDICINAL RESEARCH REVIEWS, 2022, 42 (02) :647-653
[60]   Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq [J].
Li, Guangdi ;
Xu, Ming ;
Yue, Tingting ;
Gu, Weijie ;
Tan, Li .
BIOCHEMICAL PHARMACOLOGY, 2021, 185
12345678910